Home Cart Sign in  
Chemical Structure| 187235-37-6 Chemical Structure| 187235-37-6

Structure of PA-824
CAS No.: 187235-37-6

Chemical Structure| 187235-37-6

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

PA-824 is an anti-tuberculosis drug working by both cell wall inhibition and respiratory poisoning.

Synonyms: (S)-PA 824; Pretomanid

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of PA-824

CAS No. :187235-37-6
Formula : C14H12F3N3O5
M.W : 359.26
SMILES Code : FC(F)(F)OC1=CC=C(C=C1)CO[C@H]2CN3C(OC2)=NC([N+]([O-])=O)=C3
Synonyms :
(S)-PA 824; Pretomanid
MDL No. :MFCD06809939
InChI Key :ZLHZLMOSPGACSZ-NSHDSACASA-N
Pubchem ID :456199

Safety of PA-824

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00567840 Pulmonary Tuberculosis PHASE2 COMPLETED 2025-12-07 Tiervlei Trials Center, Stelle... More >>nbosch University, Cape Town, Cape Province, 8000, South Africa|University of Cape Town Lung Institute, Cape Town, Cape Province, South Africa Less <<
NCT04309656 Multi-drug Resistant Tuberculo... More >>sis Less << PHASE1 COMPLETED 2020-02-28 Worldwide Clinical Trials Earl... More >>y Phase Services, LLC, San Antonio, Texas, 78217, United States Less <<
NCT02422524 Tuberculosis PHASE1 TERMINATED 2023-11-17 Saint Louis University Center ... More >>for Vaccine Development, Saint Louis, Missouri, 63104-1015, United States|Duke University School of Medicine - Duke Clinical Research Institute - Duke Clinical Research Unit, Durham, North Carolina, 27710-4000, United States Less <<
NCT03896750 Renal Impairment|Tuberculosis PHASE1 RECRUITING 2025-07-14 Advanced Pharma - Miami, Miami... More >>, Florida, 33147, United States|Saint Louis University Center for Vaccine Development, Saint Louis, Missouri, 63104-1015, United States|Alliance for Multispecialty Research, LLC - Knoxville, Knoxville, Tennessee, 37920, United States Less <<
NCT03202693 Tuberculosis PHASE1 COMPLETED 2025-05-06 Covance Clinical Research Unit... More >>, Madison, Wisconsin, 53704, United States Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

2.78mL

0.56mL

0.28mL

13.92mL

2.78mL

1.39mL

27.83mL

5.57mL

2.78mL

References

 

Historical Records

Categories